Status:
TERMINATED
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy
Lead Sponsor:
Saint Luke's Health System
Collaborating Sponsors:
Tyco Healthcare Group LP (d/b/a Covidien)
Conditions:
Biliary Dyskinesia
Gallstones
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will compare Single Incision Laparoscopic Surgery (SILS) cholecystectomy to traditional laparoscopic cholecystectomy (LC), focusing on patient-reported outcomes and cost.
Detailed Description
Single-Incision Laparoscopic Surgery (SILS) is accepted as a form of surgical treatment. Traditional laparoscopic cholecystectomy (TLC) is well tolerated, with a low complication risk and high patient...
Eligibility Criteria
Inclusion
- Patient recommended to undergo cholecystectomy
- Patient age 18-80
- Patient competent to give his/her own informed consent
- Patient speaks English without the need for an interpreter
Exclusion
- Additional procedures planned during same surgery
- Patient deemed inappropriate for TLC or SILS cholecystectomy
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT01195285
Start Date
February 1 2010
End Date
January 1 2012
Last Update
April 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, United States, 64111